0001415889-23-005807.txt : 20230403
0001415889-23-005807.hdr.sgml : 20230403
20230403165133
ACCESSION NUMBER: 0001415889-23-005807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230403
DATE AS OF CHANGE: 20230403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 23793515
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-04032023_080422.xml
X0407
4
2023-03-31
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
true
true
false
false
CHAIRPERSON & CEO
0
Common Stock
2023-03-31
4
M
0
8000
113.08
A
8130
D
Common Stock
2023-03-31
4
S
0
1040
218.9444
D
7090
D
Common Stock
2023-03-31
4
S
0
1906
220.04
D
5184
D
Common Stock
2023-03-31
4
S
0
861
222.1193
D
4323
D
Common Stock
2023-03-31
4
S
0
1873
223.2192
D
2450
D
Common Stock
2023-03-31
4
S
0
1087
223.8844
D
1363
D
Common Stock
2023-03-31
4
S
0
1233
220.9305
D
130
D
Common Stock
166
I
By Spouse
Common Stock
644183
I
By Trusts
Stock Options
113.08
2023-03-31
4
M
0
8000
0
D
2013-12-31
2023-12-31
Common Stock
8000
168000
D
Stock Options
120.26
2017-03-15
2026-03-15
Common Stock
294000
294000
I
By Trusts
Stock Options
146.03
2018-03-15
2027-03-15
Common Stock
240000
240000
I
By Trusts
Stock Options
146.03
2020-03-15
2027-03-15
Common Stock
100000
100000
I
By Trusts
Stock Options
146.03
2020-03-15
2027-03-15
Common Stock
244122
244122
I
By Trusts
Stock Options
146.03
2018-03-15
2027-03-15
Common Stock
150288
150288
I
By Trusts
Stock Options
111
2021-03-15
2028-03-15
Common Stock
285103
285103
I
By Trusts
Stock Options
111
2019-03-15
2028-03-15
Common Stock
213827
213827
I
By Trusts
Stock Options
135.42
2023-03-15
2027-03-15
Common Stock
500000
500000
I
By Trusts
Stock Options
117.76
2021-03-15
2027-03-15
Common Stock
500000
500000
I
By Trusts
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
This transaction was executed in multiple trades at prices ranging from $218.44 to $219.305. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $219.455 to $220.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $221.595 to $222.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $222.605 to $223.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $223.61 to $224.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $220.465 to $221.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This stock option was transferred to a trust beneficially owned by the reporting person on March 31, 2023.
/s/ John S. Hess, Jr. under Power of Attorney
2023-04-03